Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy - Suda, Kenichi; Mitsudomi, Tetsuya (Translational Lung Cancer Research; Vol 9, No 6 (December 31, 2020): Translational Lung Cancer Research, 2020)